FDA Approves Akebia’s Vafseo for Anemia in Adults with Chronic Kidney Disease on Dialysis
Approval of Vafsen (vadadustat) based on promising results from the INNO2VATE program and additional safety data from use in Japan in adults with chronic kidney disease.